Answers are grounded in this paper and cite their sources.
Authors reply to clinical insights on liver complications in systemic juvenile idiopathic arthritis, clarifying implications.
We thank Romano et al¹ for their thoughtful comments and for sharing their relevant clinical experience with systemic juvenile idiopathic arthritis (sJIA) complicated by macrophage activation syndrome (MAS) with hepatic involvement. Their report of recurrent hepatic flares requiring combined therapeutic strategies extends our observations and further supports the emerging concept of interferon (IFN)-γ–driven liver pathology in sJIA-MAS.
No takes yet. Share an insight, caveat, or question.
Eloseily et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: